Medinova Diagnostic Services Share Price

Medinova Diagnostic has an operating revenue of Rs. 9.93 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 22% is great, ROE of -63% is poor and needs improvement. NULL It is currently FORMING a base in its weekly chart and is trading around 23% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 15 which is a POOR score indicating inconsistency in earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 45 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.